BioPharmSignal logoBioPharmSignal

Biotech News

Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance

Clover Health (CLOV)Clover HealthEarnings

Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year Achieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retention Expect improving cohort economics powered by

Related news

CLOVClover Health2026-01-29 21:05 EST

Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

CLOVClover Health2026-08-05 20:05 EST

Clover Health Reports Second Quarter 2026 Results

View all latest news

Clover Health

Medicare Advantage Clover Health operates a wide-network Medicare Advantage plan designed to improve access and outcomes for older adults, including populations that have historically lacked affordable, high-quality care. Clover Assistant Its clinical model is powered by Clover Assistant, an AI-enabled software platform that aggregates...

Recent company news

CLOVClover Health2026-08-05 20:05 EST

Clover Health Reports Second Quarter 2026 Results

CLOVClover Health2026-07-22 20:05 EST

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

CLOVClover Health2026-07-09 20:05 EST

Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026

CLOVClover Health2026-07-07 12:30 EST

Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

CLOVClover Health2026-05-06 20:05 EST

Clover Health Reports First Quarter 2026 Results

Stock data

Close
4.66 USD
Market cap
1.96B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States